|
Volumn 34, Issue 5, 2016, Pages e38-e40
|
Ruxolitinib enhances platelet production in patients with thrombocytopenic myelofibrosis
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FEDRATINIB;
HEMOGLOBIN;
HYDROXYUREA;
JANUS KINASE 2;
LESTAURTINIB;
PEGINTERFERON;
PREDNISONE;
RECOMBINANT INTERFERON;
RUXOLITINIB;
THALIDOMIDE;
JAK2 PROTEIN, HUMAN;
PYRAZOLE DERIVATIVE;
ABDOMINAL PAIN;
ADULT;
ARTHRALGIA;
ARTICLE;
BLOOD TRANSFUSION;
CASE REPORT;
CONSTIPATION;
DIARRHEA;
DRUG WITHDRAWAL;
DYSPNEA;
ERYTHROCYTE TRANSFUSION;
EXERCISE TOLERANCE;
EXTRAMEDULLARY HEMATOPOIESIS;
FATIGUE;
FEMALE;
HUMAN;
IRRADIATION;
LABORATORY TEST;
LEG EDEMA;
MIDDLE AGED;
MYELOFIBROSIS;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHLEBOTOMY;
PHYSICAL EXAMINATION;
POLYCYTHEMIA VERA;
PRIORITY JOURNAL;
PRURITUS;
SATIETY;
SIDE EFFECT;
SPLEEN INFARCTION;
SPLENOMEGALY;
THROMBOCYTE COUNT;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
THROMBOCYTOPENIC MYELOFIBROSIS;
THROMBOCYTOPOIESIS;
ANTAGONISTS AND INHIBITORS;
GENETICS;
MUTATION;
PATHOLOGY;
PHYSIOLOGY;
PRIMARY MYELOFIBROSIS;
PROGNOSIS;
THROMBOCYTE;
BLOOD PLATELETS;
FEMALE;
HUMANS;
JANUS KINASE 2;
MIDDLE AGED;
MUTATION;
POLYCYTHEMIA VERA;
PRIMARY MYELOFIBROSIS;
PROGNOSIS;
PYRAZOLES;
THROMBOCYTOPENIA;
|
EID: 84958973171
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2013.51.0057 Document Type: Article |
Times cited : (11)
|
References (10)
|